Bortezomib

Bortezomib is a prescription medication used to treat multiple myeloma, a type of blood cancer. It belongs to a class of drugs called proteasome inhibitors, which work by blocking the activity of specific proteins in cancer cells. This helps to stop the growth of cancer cells and may also help the body to destroy them. Bortezomib is usually used in combination with other medications and is given by injection into a vein or under the skin. Common side effects include nausea, diarrhea, and tiredness.

Bortezomib, sold under the brand name Velcade, is a potent medication used to treat several types of cancer, particularly multiple myeloma. Here's a detailed description:

What it is:

  • Bortezomib belongs to a class of medications called proteasome inhibitors. Proteasomes are complex protein structures within cells responsible for breaking down and recycling unwanted or damaged proteins.
  • Bortezomib works by inhibiting the function of proteasomes, leading to the buildup of abnormal proteins within cancer cells. This accumulation eventually triggers cell death in the targeted cancer cells.

What it's used for:

  • Multiple myeloma: Bortezomib is primarily used to treat multiple myeloma, a cancer of the plasma cells (a type of white blood cell) that reside in the bone marrow. It is often used:
    • As part of combination therapy: Combined with other medications, such as corticosteroids and other chemotherapy drugs.
    • For relapsed or refractory multiple myeloma: When the cancer returns (relapses) after initial treatment or does not respond well to other treatments (refractory).
  • Other potential uses: Bortezomib is also being investigated for its effectiveness in treating other types of cancers, such as mantle cell lymphoma and amyloidosis.

How it's used:

  • Bortezomib is typically administered by injection (intravenously) into a vein, usually on a specific schedule depending on the treatment plan and specific situation.

Important points to remember:

  • Bortezomib is a powerful medication with potentially serious side effects, including:
    • Peripheral neuropathy (numbness, tingling, or pain in the hands and feet)
    • Fatigue
    • Nausea and vomiting
    • Diarrhea
    • Low blood cell counts
    • Increased risk of infection
  • Bortezomib can interact with other medications, so it is crucial to inform your doctor about all medications you are taking, including prescription and over-the-counter drugs, vitamins, and herbal supplements.
  • It is not recommended for everyone, especially individuals with certain medical conditions, severe kidney problems, or pregnant or breastfeeding women.

It is important to note that:

  • I am not a medical professional and this information should not be taken as medical advice.
  • Bortezomib is a prescription medication and should only be used under the supervision of a qualified healthcare professional, typically an oncologist specializing in cancer treatment.
  • Always consult your doctor about any questions or concerns you may have about Bortezomib or any other medication.
Anatomical Therapeutic Chemical Classification
L - Antineoplastic and immunomodulating agents
L01 Antineoplastic agents
L01X - Other antineoplastic agents
L01XG Proteasome inhibitors
External Links